All In MedTech

FDA Clearance Tracker · P090016-S066

Belotero Balance (+) Lidocaine Dermal Filler

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 10, 2025

Approved

Time to decision

87 days

Received Jul 15, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P090016-S066
Device name
Belotero Balance (+) Lidocaine Dermal Filler
Applicant location
Franksville, WI
Received
Jul 15, 2025
Decided
Oct 10, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P090016

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

approval for a change to the release and shelf-life specifications for Belotero Balance (+) Lidocaine Dermal Filler

Source documents

Other decisions for Merz North America, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

6 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.